TownSquare Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $410K | Buy |
7,107
+413
| +6% | +$23.7K | 0.08% | 194 |
|
|
2026
Q1 | $406K | Buy |
6,694
+873
| +15% | +$50.9K | 0.09% | 172 |
|
|
2025
Q4 | $314K | Sell |
5,821
-6,344
| -52% | -$305K | 0.07% | 186 |
|
|
2025
Q3 | $549K | Sell |
12,165
-6,857
| -36% | -$320K | 0.08% | 200 |
|
|
2025
Q2 | $881K | Sell |
19,022
-243,151
| -93% | -$11.9M | 0.09% | 226 |
|
|
2025
Q1 | $16M | Buy |
262,173
+34,874
| +15% | +$2.03M | 0.17% | 107 |
|
|
2024
Q4 | $12.9M | Buy |
227,299
+77,605
| +52% | +$4.34M | 0.15% | 126 |
|
|
2024
Q3 | $7.75M | Buy |
149,694
+25,324
| +20% | +$1.19M | 0.09% | 210 |
|
|
2024
Q2 | $5.17M | Buy |
124,370
+4,908
| +4% | +$220K | 0.07% | 257 |
|
|
2024
Q1 | $6.48M | Buy |
119,462
+6,806
| +6% | +$347K | 0.09% | 203 |
|
|
2023
Q4 | $5.78M | Buy |
112,656
+8,630
| +8% | +$453K | 0.1% | 197 |
|
|
2023
Q3 | $6.04M | Sell |
104,026
-8,541
| -8% | -$523K | 0.11% | 175 |
|
|
2023
Q2 | $7.2M | Buy |
112,567
+11,796
| +12% | +$791K | 0.13% | 159 |
|
|
2023
Q1 | $6.98M | Buy |
100,771
+5,519
| +6% | +$389K | 0.15% | 122 |
|
|
2022
Q4 | $6.85M | Buy |
95,252
+17,374
| +22% | +$1.31M | 0.17% | 115 |
|
|
2022
Q3 | $5.54M | Buy |
77,878
+8,359
| +12% | +$606K | 0.16% | 117 |
|
|
2022
Q2 | $5.35M | Sell |
69,519
-1,517
| -2% | -$116K | 0.15% | 120 |
|
|
2022
Q1 | $5.19M | Buy |
71,036
+13,999
| +25% | +$940K | 0.13% | 144 |
|
|
2021
Q4 | $3.56M | Buy |
57,037
+3,646
| +7% | +$214K | 0.09% | 189 |
|
|
2021
Q3 | $3.16M | Buy |
53,391
+4,968
| +10% | +$327K | 0.09% | 195 |
|
|
2021
Q2 | $3.23M | Buy |
48,423
+11,064
| +30% | +$721K | 0.1% | 170 |
|
|
2021
Q1 | $2.36M | Buy |
37,359
+3,528
| +10% | +$220K | 0.09% | 183 |
|
|
2020
Q4 | $2.1M | Buy |
33,831
+3,468
| +11% | +$213K | 0.09% | 182 |
|
|
2020
Q3 | $1.75M | Sell |
30,363
-2,221
| -7% | -$134K | 0.1% | 164 |
|
|
2020
Q2 | $1.88M | Buy |
32,584
+4,097
| +14% | +$245K | 0.13% | 133 |
|
|
2020
Q1 | $1.72M | Sell |
28,487
-743
| -3% | -$45.4K | 0.14% | 121 |
|
|
2019
Q4 | $1.88M | Sell |
29,230
-4,245
| -13% | -$243K | 0.15% | 119 |
|
|
2019
Q3 | $1.93M | Buy |
33,475
+2,974
| +10% | +$140K | 0.16% | 112 |
|
|
2019
Q2 | $1.4M | Sell |
30,501
-4,059
| -12% | -$189K | 0.13% | 125 |
|
|
2019
Q1 | $1.65M | Buy |
34,560
+12,915
| +60% | +$643K | 0.13% | 125 |
|
|
2018
Q4 | $1.08M | Buy |
+21,645
| New | +$1.16M | 0.14% | 130 |
|
Other funds holding BMY
TownSquare Capital's BMY Position: Q2 2026 in Review
TownSquare Capital increased its Bristol-Myers Squibb (BMY) stake by 6.2% in Q2 2026, buying an estimated $23.7K and bringing the position to 7,107 shares worth $410K. The position accounts for 0.08% of the portfolio, ranked #194.
TownSquare Capital first reported a position in BMY in Q4 2018 and has held it in 31 quarters since. The position peaked at $16M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- TownSquare Capital held 7,107 shares of Bristol-Myers Squibb worth $410K as of Q2 2026.
- TownSquare Capital bought 413 Bristol-Myers Squibb shares in Q2 2026, an estimated $23.7K.
- Bristol-Myers Squibb made up 0.08% of TownSquare Capital's portfolio in Q2 2026, its #194 holding.
- TownSquare Capital first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 31 quarters since.
- TownSquare Capital's Bristol-Myers Squibb position peaked at $16M in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on TownSquare Capital's 13F filing for Q2 2026, filed 14 Aug 2026.